Search
for
Sort by
Research 451–480 of 1000+
- Bimatoprost
- 319 Novel Circulating Natural Killer Cell Subset as Biomarkers in Alopecia Areata Progression
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
- Review of Baricitinib in the Treatment of Alopecia Areata.
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Longitudinal Assessment of the Prevalence of Actinic Keratosis and Extensive Risk Factor Evaluation: An Update from the Rotterdam Study
- Baricitinib for the Treatment of Alopecia Areata
- Exploring novel management options for alopecia areata
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- No. 350-Hirsutism: Evaluation and Treatment
- BH20 An unintended sequela of hair regrowth: severe Janus kinase inhibitor-associated acneiform eruption in alopecia areata
- 52898 Among scalp non-responder patients with eyebrow/eyelash regrowth in the first year, continued treatment with baricitinib resulted in meaningful scalp responses for patients with severe alopecia areata
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Analysis and clinical determinants of post-COVID-19 syndrome in the Lombardy region: evidence from a longitudinal cohort study
- Characterization of lipid profile in psoriasis, acne vulgaris, and androgenetic alopecia: a case–control study
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- COVID-19 and hypopituitarism
- Efficacy and safety of metformin for melasma treatment: a systematic review and meta-analysis
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- LEVERAGING MACHINE LEARNING METHODS IN PREDICTING AND ANALYZING THE ASSOCIATION BETWEEN DIETARY INFLAMMATORY INDEX AND ALOPECIA
- The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Comparison of efficacy, safety and satisfaction of latanoprost versus minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial
- ChatGPT in medicine: Evaluating psoriasis patient concerns
- The effect of latanoprost 0.005% solution in the management of scalp alopecia areata, a randomized double‐blind placebo‐controlled trial
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- COMPARATIVE EVALUATION OF EFFICACY AND SAFETY OF TOPICAL METHOTREXATE WITH TRETINOIN VERSUS BETAMETHASONE WITH TRETINOIN IN PATIENTS OF ALOPECIA AREATA: A PROSPECTIVE RANDOMIZED DOUBLE-BLIND STUDY